Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000–17: a spatial and temporal modelling study
Katherine E Battle, Tim CD Lucas, Michele Nguyen, Rosalind E Howes, Anita K Nandi, Katherine A Twohig, Daniel A Pfeffer, Ewan Cameron, Puja C Rao, Daniel Casey, Harry S Gibson, Jennifer A Rozier, Ursula Dalrymple, Suzanne H Keddie, Emma L Collins, Joseph R Harris, Carlos A Guerra, Michael P Thorn, Donal Bisanzio, Nancy Fullman, Chantal K Huynh, Xie Kulikoff, Michael J Kutz, Alan D Lopez, Ali H Mokdad, Mohsen Naghavi, Grant Nguyen, Katya Anne Shackelford, Theo Vos, Haidong Wang, Stephen S Lim, Christopher JL Murray, Ric N Price, J Kevin Baird, David L Smith, Samir Bhatt, Daniel J Weiss, Simon I Hay, Peter W Gething
2019-07-27
Abstract:BackgroundPlasmodium vivax exacts a significant toll on health worldwide, yet few efforts to date have quantified the extent and temporal trends of its global distribution. Given the challenges associated with the proper diagnosis and treatment of P vivax, national malaria programmes—particularly those pursuing malaria elimination strategies—require up to date assessments of P vivax endemicity and disease impact. This study presents the first global maps of P vivax clinical burden from 2000 to 2017.MethodsIn this spatial and temporal modelling study, we adjusted routine malariometric surveillance data for known biases and used socioeconomic indicators to generate time series of the clinical burden of P vivax. These data informed Bayesian geospatial models, which produced fine-scale predictions of P vivax clinical incidence and infection prevalence over time. Within sub-Saharan Africa, where routine …